Trending Now
AGC Biologics achieves the on-schedule Completion of a drug substance PPQ...
AGC Biologics strives to offer scaled expertise in the manufacturing of protein-based therapeutics through its integrated service offerings. Its interest begins right from the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Amgen, Inc. (NASDAQ:AMGN) And Its Partners Release GALACTIC-HF Phase 3 Trial...
Amgen, Inc. (NASDAQ:AMGN) and its partners Servier and Cytokinetics, Incorporated (NASDAQ:CYTK) recently disclosed the topline results of their Phase 3 trial of a developmental...
MAKE IT MODERN
LATEST REVIEWS
Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) Receives Funding from MTEC for the Second...
Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) has announced a new randomized, investigational trial for razuprotafib. In collaboration with the Medical Technology Enterprise Consortium (MTEC), the company...
MAKE IT MODERN
PERFORMANCE TRAINING
Vericel Corporation Inc. (NASDAQ:VCEL) Posts Net Revenue Of $32.3 Million In Q3 2020
Vericel Corporation Inc. (NASDAQ:VCEL) has announced its Q3 2020 financial results posting net revenue of $32.3 million and also provided business updates.
Vericel reports total...
CureVac BV (NASDAQ: CVAC)’s Market Value Drops Significantly After Its COVID Vaccine Is Only...
CureVac BV (NASDAQ: CVAC)’s market value dropped by several billion Euros after its coronavirus vaccine proved to be 47% active in the initial studies....
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 vaccine booster shot is under review by the EU regarding the possibility of administration after six months of the...
Moderna Inc. (NASDAQ:MRNA) Expects COVID-19 Vaccine Efficacy Data By Thanksgiving With Insiders Warming To...
Executives of Moderna Inc. (NASDAQ:MRNA) have been slowly unwinding their position despite the lockup period still being in place.
Moderna executives selling shares ahead of...
Equillium Inc (NASDAQ:EQ) Reports Favorable Results From itolizumab Clinical Trials
Equillium Inc (NASDAQ:EQ) and its partner Biocon Limited have announced favorable findings from a clinical trial of itolizumab as a treatment for cytokine release...
MAKE IT MODERN
